Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
Antibody targeting TSLP achieves positive results in asthma study
Activating human killer T-cells against cancer
Spinal Muscular Atrophy Awareness Month begins with spotlight on care gaps
University of Aberdeen-led team to trial new drug for heavy menstrual bleeding
Bristol Myers Squibb announces $2.3bn campus in Texas
Mironid raises $46m to advance clinical development of rare kidney disease treatment
Foundation for Angelman Syndrome Therapeutics announces agreement with Apertura Gene Therapy for access to blood-brain barrier-crossing capsid
3D genome mapping in rare immune cells reveals new Crohn’s genes
Cancer cells hijack a fatty acid to escape immune attack in liver metastases